Original language | English (US) |
---|---|
Pages (from-to) | 217-218 |
Number of pages | 2 |
Journal | Neuropsychopharmacology |
Volume | 44 |
Issue number | 1 |
DOIs | |
State | Published - Jan 1 2019 |
Bibliographical note
Funding Information:This work is supported by a Hennepin Healthcare Research Institute award (M.P.), and by the NIH under grants U01 DA038876 (M.P.), R01 DA041730 (M.P.), and T32DA007097 (C.B.).Competing interests: M.P. is the inventor of “Cytokine Signaling Immunomodulators and Methods,” International Application No. PCT/US2017/031907 filed on May 10, 2017. C.B. declares no competing interests.
Funding Information:
This work has been supported by funds from the Centre National de la Recherche Scientifique, the Institut National de la Santé et de la Recherche Médicale, the Sorbonne Universités, and by grants from the Fondation pour la Recherche sur le Cerveau, the Fondation de France, the Région Ile-de-France, the Fondation pour la
Copyright:
Copyright 2019 Elsevier B.V., All rights reserved.
Keywords
- Drug Overdose/prevention & control
- Humans
- Opioid-Related Disorders/therapy
- Vaccines
PubMed: MeSH publication types
- News
- Research Support, N.I.H., Extramural
- Research Support, Non-U.S. Gov't